Selecting the "right" mouse model for metabolic syndrome and type 2 diabetes research
- PMID: 19504239
- DOI: 10.1007/978-1-59745-448-3_1
Selecting the "right" mouse model for metabolic syndrome and type 2 diabetes research
Abstract
This is not a "Methods" chapter in the traditional sense. Rather, it is an essay designed to help address one of the most frequently asked questions by investigators about to embark on a study requiring an animal model of diabetes - what is the "right" model for the reader's specific research application. Because genetic heterogeneity and the requirement for complex gene-environment interaction characterize the various mouse models of Type 2 diabetes as well as the human disease manifestations, the readers may come to share the author's conclusion that more than one model is required if the investigator is interested in knowing how broadly effective a given compound with putative therapeutic efficacy might be.
Similar articles
-
Pathophysiology and genetics of obesity and diabetes in the New Zealand obese mouse: a model of the human metabolic syndrome.Methods Mol Biol. 2012;933:59-73. doi: 10.1007/978-1-62703-068-7_5. Methods Mol Biol. 2012. PMID: 22893401
-
The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome.Results Probl Cell Differ. 2010;52:1-11. doi: 10.1007/978-3-642-14426-4_1. Results Probl Cell Differ. 2010. PMID: 20865367 Review.
-
Are animal models of diabetes relevant to the study of the genetics of non-insulin-dependent diabetes in humans?Diabetes Metab. 1997 Mar;23 Suppl 2:38-46. Diabetes Metab. 1997. PMID: 9105782 Review.
-
Experimental rat models to study the metabolic syndrome.Br J Nutr. 2009 Nov;102(9):1246-53. doi: 10.1017/S0007114509990729. Epub 2009 Jul 27. Br J Nutr. 2009. PMID: 19631025 Review.
-
Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes.J Periodontal Res. 2009 Feb;44(1):43-51. doi: 10.1111/j.1600-0765.2007.01060.x. Epub 2008 Oct 7. J Periodontal Res. 2009. PMID: 18973548
Cited by
-
GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: a treatment for metabolic syndrome.BMC Complement Med Ther. 2022 Mar 8;22(1):62. doi: 10.1186/s12906-022-03538-9. BMC Complement Med Ther. 2022. PMID: 35260150 Free PMC article.
-
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1272-C1290. doi: 10.1152/ajpcell.00446.2023. Epub 2024 Mar 4. Am J Physiol Cell Physiol. 2024. PMID: 38602847 Free PMC article.
-
Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes.Biology (Basel). 2020 Oct 22;9(11):347. doi: 10.3390/biology9110347. Biology (Basel). 2020. PMID: 33105667 Free PMC article.
-
Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome Community.Sci Rep. 2018 May 25;8(1):8166. doi: 10.1038/s41598-018-26506-1. Sci Rep. 2018. PMID: 29802368 Free PMC article.
-
Effects of high-intensity interval training and moderate-intensity continuous training on glycaemic control and skeletal muscle mitochondrial function in db/db mice.Sci Rep. 2017 Mar 16;7(1):204. doi: 10.1038/s41598-017-00276-8. Sci Rep. 2017. PMID: 28303003 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical